Rivals Await CHMP Decisions On Drugs For NMOSD

 
• By Neena Brizmohun

The European Medicines Agency’s drug evaluation committee, the CHMP, is this week considering products from Alexion Pharmaceuticals and Roche/Chugai Pharmaceutical who are both vying for a share of the as yet untapped EU market for neuromyelitis optica spectrum disorder.

3d render of Europe map Earth globe
The CHMP is discussing marketing applications for new drugs in Europe this week. • Source: Shutterstock

More from Europe

More from Geography